Biota (BTA): One company that seems poised to surprise to the upside this year is former market darling Biota. The UK government has just placed a large order for anti-influenza serum with partner GlaxoSmithKline, which means Biota will enjoy a spike in royalties this year. Analysts at ABN-Amro already predicted Biota should easily beat current year's earnings expectation
- Forums
- ASX - By Stock
- BTA
- dr. anne moscona in the la times
dr. anne moscona in the la times, page-7
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online